No Data
No Data
Express News | Sensei Biotherapeutics Inc : Stephens Initiates With Overweight Rating and $5 Price Target
Sensei Biotherapeutics Initiated at Overweight by Stephens & Co.
Sensei Biotherapeutics Initiated at Overweight by Stephens & Co.
Express News | Stephens & Co. Initiates Coverage On Sensei Biotherapeutics With Overweight Rating, Announces Price Target of $5
Sensei Biotherapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/14/2024 195.86% Stephens & Co. → $5 Initiates Coverage On → Overweight 12/04/2023 136.69% HC Wainwright
Buy Rating Justified for Sensei Biotherapeutics Amidst Strong Pipeline and Financial Stability
Sensei Biotherapeutics Poised for Growth: A Strong Buy Rating Amid Financial Stability and Promising Clinical Trials
No Data